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Introduction: Fluid administration is a first-line therapy for acute kidney injury associated with circulatory failure.
Although aimed at increasing renal perfusion in these patients, this intervention may improve systemic hemodynamics
without necessarily ameliorating intrarenal flow distribution or urine output. We used Doppler techniques to investigate
the effects of fluid administration on intrarenal hemodynamics and the relationship between changes in renal
hemodynamics and urine output. We hypothesized that, compared to systemic hemodynamic variables, changes in
renal hemodynamics would better predict increase in urine output after fluid therapy.
Methods: We measured systemic hemodynamic variables and performed renal interlobar artery Doppler on both
kidneys before and after volume expansion in 49 adult patients with acute circulatory failure. We measured systolic and
diastolic velocities and computed the resistivity index (RI). We recorded urine output for 3 h before and after the fluid
challenge.
Results: Fluid administration resulted in a small but consistent decrease in RI (from 0.73 ± 0.09 to 0.71 ± 0.09, p < 0.01).
There was a concomitant increase in mean arterial pressure (from 75 ± 15 to 80 ± 14 mmHg, p < 0.01), pulse pressure
(49 ± 19 to 55 ± 19 mmHg, p < 0.01) and urine output (55 ± 76 to 81 ± 87 ml/hour, p < 0.01). Changes in RI
were negatively correlated with changes in urine output and mean arterial pressure but not in pulse pressure. The
increase in urine output was predicted by changes in RI but not by changes in systemic hemodynamics.
Conclusions: Changes in renal hemodynamics during a fluid challenge can be observed by Doppler ultrasonography
before urine output increases. Moreover, these changes are better predictors of an increase in urine output than are
mean arterial pressure and pulse pressure.Introduction
Imbalance in oxygen delivery and oxygen demand is
common in critically ill patients, especially those with
acute circulatory failure of septic, hypovolemic or
cardiogenic origin. Acute kidney injury (AKI) is a frequent
complication of circulatory failure and associated with
increased morbidity and mortality [1, 2]. Fluid resuscita-
tion is a first-line therapy used to restore oxygen delivery
to the organs and prevent AKI [1–3] and yet the
renal effects of fluid resuscitation are not easily assessed.
Excessive fluid administration may have harmful effects,
and mortality rates are increased in patients with AKI
who develop a positive fluid balance [4–6]. Hence, it could
be important to identify those patients in whom renal* Correspondence: jlvincen@ulb.ac.be
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fluids are often given to patients with AKI with the aim of
increasing renal perfusion, physicians generally evaluate
the effectiveness of fluid therapy by looking at systemic
hemodynamic variables, such as mean arterial pressure
(MAP) or cardiac output, because the increase in urine
output may be delayed or inconsistent and the decrease in
serum creatinine may be even slower. A direct evaluation
of renal hemodynamics would be valuable, but is not
easily obtained at the bedside.
Recently, interlobar artery (ILA) resistivity index (RI),
a reliable surrogate of intrarenal vascular tone measured by
renal interlobar artery Doppler (RIAD), has been proposed
for bedside evaluation of intrarenal hemodynamics in
critically ill patients [7–9]. This index has been used to
identify septic patients who develop AKI several days after
ICU admission [7], and to separate patients who developrticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
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analysis of nine trials suggested that elevated RI was
significantly associated with persistent AKI [11]. This
variable has also been successfully used in critically ill
patients to evaluate changes in renal hemodynamics
following various therapeutic interventions, such as
norepinephrine infusion, fluid challenge, mild hypoxemia
or paracentesis [8–13]. However, none of these studies
compared the effectiveness of changes in systemic and in
intrarenal hemodynamics to predict changes in urine
output after a fluid challenge.
The aim of this study was to evaluate changes in ILA
RI, using Doppler techniques, during volume expansion
in critically ill patients and, in addition, to compare the
performance of these changes with that of changes in
systemic hemodynamics for the prediction of subsequent
variations in urine output. We hypothesized that dynamic
analysis of intrarenal hemodynamics using RIAD following
a fluid challenge may help to identify responders to fluids
better than systemic hemodynamics.
Methods
Setting and patients
Erasme University Hospital Ethics Committee approved
this interventional study (P2011/125) and informed
consent was obtained from the patients or their next of
kin. In a convenience sample of patients admitted
between April 2011 and March 2012, three groups
were studied: two control groups and an interventional
group. The control groups included ICU patients with
stable systemic hemodynamics receiving no specific
intervention. In the first control group, A, we evaluated
intra-observer variability in RIAD measurements by per-
forming three measurements 15 min apart. The ultrasound
measurements for this assessment were performed by the
same technician but the calculations of RI were performed
by a statistician not involved in the measurements or
the design of the study. In control group B, we assessed
stability of the Doppler variables over time, by performing
two measurements 60 min apart.
The interventional group consisted of patients with
acute circulatory failure who required a fluid challenge.
Acute circulatory failure was defined as the association of
arterial hypotension (systolic arterial pressure <90 mmHg
or MAP <65 mmHg) or need for vasopressor to cor-
rect hypotension, and/or oliguria defined as urine
output <0.5 ml/kg/hour with at least one of the fol-
lowing criteria: impaired mentation, mottled extrem-
ities, arterial lactate >2 mmol/l, and superior vena
cava (ScvO2) or mixed (SvO2) venous oxygen satura-
tions <70 % or <65 %, respectively. Exclusion criteria
were age <18 years, atrial fibrillation or frequent ven-
tricular arrhythmias, history of renal transplantation
or stenosis of renal arteries, end-stage renal disease,known unilateral kidney, pregnancy, and body mass
index >40 kg/m2. Patients were also excluded from the
study if they were given diuretics or there were any
changes in vasopressor administration during the study
period. AKI was defined as an increase in serum creatin-
ine ≥0.3 mg/dl over 24 h and/or a 1.5-fold increase in
baseline serum creatinine over 7 days, and/or oliguria with
a reduction in urine output <0.5 ml/kg/hour over 6 h [14].
Systemic hemodynamics and renal Doppler measurements
Monitoring included continuous electrocardiogram and
heart rate recording and invasive measurement of MAP
and pulse pressure (PP) through a radial or femoral
catheter. We also measured arterial lactate and ScvO2/
SvO2. One investigator (MDM) performed all Doppler
measurements using a convex 2–5.5 MHz probe (4C RS,
General Electric Healthcare, Diegem, Belgium), with the
transducer applied in a lateral or postero-lateral view to
visualize the kidneys. Intrarenal vessels were observed
using color Doppler, then a pulsed Doppler signal was
obtained on the ILA. Three consecutive measurements
displaying at least three ILA Doppler waves each (corre-
sponding to three cardiac beats) were performed in the
upper, middle and lower poles of both kidneys and aver-
aged. Failure to meet these criteria or a difference of
more than 5 % in RI between the kidneys was considered
as a failure in measurement. Systolic (SV) and diastolic
(DV) velocities were measured on each wave. Interlobar
RI was calculated using the formula: RI = (SV – DV)/SV.
Study protocol
Fluid challenge consisted of a minimum volume of 500 ml
crystalloid (NaCl 0.9 %, Hartman’s or Plasmalyte solution
(Baxter, Lessines, Belgium) or hydroxyethyl starch 6 %
(Voluven, Fresenius, Bad Homburg, Germany)) infused
at a minimum rate of 1,000 ml/hour under arterial
pressure guidance [15]. Fluid administration was
stopped when MAP reached a predetermined goal
(generally MAP >65 mmHg, and/or MAP and/or stroke
volume increase >10–15 % compared to baseline) and/
or central venous pressure increased >15 mmHg.
Systemic hemodynamic variables were recorded and
renal Doppler measurements were performed before
and at the end of the fluid challenge. The urine output
volumes over the 3 h preceding and following the fluid
challenge were recorded (Fig. 1).
Statistical analysis
Our primary objective was to describe whether the fluid
challenge induced changes in RI. Our secondary objective
was evaluation of the relationship between changes in
renal Doppler and urine output. We evaluated the
performance of renal RI, compared to MAP and PP, to pre-
dict an increase in urine output after fluid administration
Fig. 1 Summary of the study design. The intervention was a fluid challenge that consisted of infusion of a minimum volume of 500 ml at a
minimum rate of 1,000 ml/hour. Interlobar artery Doppler variables, blood pressure, heart rate and urine output were recorded before and after
the fluid challenge and stabilization of hemodynamic variables. UO/3H: urine output volumes measured over 3 hours
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thresholds: increase in urine output by at least 0.1 ml/kg/
hour, 0.2 ml/kg/hour and 0.3 ml/kg/hour. The 0.3 ml/kg/
hour threshold was used because such an increase in urine
output implies improvement to a better class of the AKIN
[14] or RIFLE [16] classifications.
We also separated patients into systemic hemodynamic
responders (increase in MAP or PP >10 % after fluid
challenge) and non-responders to fluid challenge.
Change in RI was calculated as the difference in RI
divided by baseline RI. Similarly, changes in MAP and
PP were calculated as the absolute difference observed
after fluid challenge divided by the baseline value.
Data distribution was verified using a Kolmogorov-
Smirnov test. Continuous variables are presented as median
(interquartile range) or mean ± standard deviation. Baseline
characteristics of responders and non-responders wereFig. 2 Study Consort diagram. *Six patients had two Doppler waves instea
the kidneys. RIAD renal interlobar artery Dopplercompared using Fisher’s exact test or chi square test and
Mann Whitney’s rank sum test as appropriate. In control
group A, an intraclass correlation was used to evaluate vari-
ability of measurements. In control group B, we calculated
the coefficient of variation (CV) of RI and computed the
coefficient of error (CE) using the formula CE =CV/√n,
where n is the number of measurements in each patient.
The precision of the RI measurements was calculated as
two CE for average measurements with a level ≤10 %
considered acceptable as recommended [17]. We
computed the least significant change (LSC), which is
the lowest degree of change between two measurements
over time that must be exceeded to consider a change to be
significant (confidence interval 95 %), using the equation
LSC =CE × 1.96 × √2.
In the intervention group, paired Student’s t test or
Wilcoxon rank test were used for paired comparisons.d of three or more, two patients had >5 % difference in RI between
Table 1 Demographic characteristics of patients at baseline
(interventional group, n = 49)
Characteristic Value
Age (years) 62 ± 16.4
Male, n (%) 34 (69)
Weight (Kg) 80 ± 16
Mechanical ventilation, n (%) 33 (67.3)
Vte (ml) 499 ± 82
PEEP (cmH2O) 6 ± 1.2
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examined for correlations using Pearson’s linear correlation
coefficient. In subgroups of patients (AKI or no-AKI, oli-
guria or no-oliguria, fluid challenge systemic hemodynamic
responder and non-responder), median values were com-
pared using the Wilcoxon rank test and linear correlation
was verified using Spearman’s correlation coefficient. A
mix model analysis was performed considering subgroups
and the time of measurement.
Receiver operating characteristic curves were generated
to test the predictive discrimination of renal responders
and non-responders to fluid therapy. Areas under the curve
of changes in Doppler variables and of changes in systemic
hemodynamic variables were generated and tested for
significant differences using the DeLong test. These
analyses were also performed for systemic hemodynamic
fluid responsiveness. Significance was assumed for a
two-sided p value < 0.05. All statistical analyses were
performed using SPSS 19 for Windows (IBM SPSS
Statistics, Chicago, IL, USA).
Results
We studied 29 patients in the control groups (A, n = 18
and B, n = 11) to evaluate the variability of the renal
Doppler measurements (Fig. 2): RI remained stable over
1 h of observation (Fig. 3), with a precision level of 0.9 %
(0.3–1.2 %), far below the usually admitted 10 % level.
The LSC was 0.01. The intraclass correlation coefficient
of three RI measurements 15 min apart was excellent
(0.998, p < 0.001).Fig. 3 Individual changes in RI over time in the non-intervention
group (Control group B). Each line corresponds to the change in
RI in one stable ICU patient. Measurements were performed at
baseline and 1 hour later in stable hemodynamic conditions with
no interventionOf the 80 patients assessed for inclusion in the interven-
tion group, 31 were excluded (eight for failure to obtain
adequate renal Doppler measurements (six patients had
two Doppler waves instead of at least three, and two
patients had >5 % difference in RI between the kidneys)
and 23 for concurrent changes in vasoactive support)
(Fig. 2). The demographic characteristics of the remaining
49 patients are presented in Table 1. At baseline, 20 (41 %)
patients had arterial hypotension, 7 (14 %) had normoten-
sion under vasopressor therapy, and 27 (55 %) had oliguria
(of these 22 had oliguria without hypotension or vasopres-
sor therapy). The arterial lactate level was elevated in 20
(53 %) patients and ScvO2 or SvO2 was low in 13 (68 %).
The patients received 1,224 ± 717 ml of fluids, primarily as
crystalloids (Table 2). Fluid administration resulted in
increases in MAP from 75 ± 15 to 80 ± 14 mmHg (p < 0.01;
Fig. 4), and PP from 49 ± 19 to 55 ± 19 mmHg (p < 0.01;
Fig. 4). RI decreased concurrently from 0.73 ± 0.09 toPaO2 (mmHg) 91 ± 25
FiO2 (%) 50 ± 20
Type of patient, n (%)
Medical 26 (53)
Surgical 23 (47)





Acute Physiology and Chronic Health Evaluation score 22.4 ± 7.8
Sequential Organ Failure Assessment score 8.8 ± 5.3
RIFLE score
Risk, n (%) 13 (26.5)
Injury, n (%) 11 (22.4)
Failure, n (%) 7 (14.3)
Loss, n (%) 6 (12.2)
ESKD, n (%) 1 (2)
Results given as mean ± standard deviation, or frequency (percentage). FiO2
inspiratory oxygen fraction, PaO2 arterial oxygen pressure, PEEP positive
end-expiratory pressure, RIFLE Risk (R), Injury (I), Failure (F), Loss (L), End-stage
kidney disease (ESKD), Vte expiratory tidal volume
Table 2 Hemodynamic characteristics of renal responders and non-responders at baseline
Variables All 0.1 ml/kg/hour 0.2 ml/kg/hour 0.3 ml/kg/hour
R NR R NR R NR
N 49 32 16 27 21 25 23
Heart rate (bpm) 98 ± 23 98 ± 22 97 ± 27 101 ± 22 94 ± 25 101 ± 22 94 ± 24
Systolic arterial pressure (mmHg) 109 ± 21 113 ± 24 102 ± 13 116 ± 25* 101 ± 12 117 ± 25* 101 ± 12
Diastolic arterial pressure (mmHg) 58 ± 13 60 ± 15 53 ± 8 63 ± 15* 52 ± 8 64 ± 15* 52 ± 8
Mean arterial pressure (mmHg) 75 ± 16 79 ± 17 70 ± 9 80 ± 17* 68 ± 8.9 82 ± 17* 68 ± 8.9
Pulse pressure (mmHg) 48 ± 19 50 ± 20 46 ± 17 51 ± 22 47 ± 15 50 ± 22 47 ± 15
Resistivity index 0.73 ± 0.09 0.71 ± 0.09* 0.77 ± 0.06 0.70 ± 0.09* 0.77 ± 0.63 0.70 ± 0.09* 0.76 ± 0.06
Systolic velocity (cm/s) 42.8 ± 17.7 42.2 ± 16.4 45.6 ± 19.9 41.7 ± 14.3 45.3 ± 21.2 43.3 ± 13.5 43.3 ± 21.4
Diastolic velocity (cm/s) 11.4 ± 5.9 12.2 ± 6.4 10.2 ± 4.7 12.7 ± 6.5 10 ± 4.6 13.2 ± 6.6 9.7 ± 4.5
Mean velocity (cm/s) 21.8 ± 9.1 27.2 ± 10.7 27.9 ± 11.8 27.2 ± 9.9 27.7 ± 12.6 28.2 ± 9.5 26.5 ± 12.6
Urine output (ml/kg/hour) 0.69 ± 1.04 0.73 ± 0.85 0.65 ± 1.39 0.79 ± 0.88 0.61 ± 1.24 0.83 ± 0.9 0.57 ± 1.19
Lactate, mean value (mmol/l) 2.8 ± 2.6 2.7 ± 2.5 3.1 ± 3.1 2.8 ± 2.6 2.8 ± 2.8 2.9 ± 2.7 2.8 ± 2.6
Number, n (%) 41 (83.7) 28 (87.5) 12 (75) 23 (85.2) 17 (80.1) 21 (84) 19 (82.6)
ScvO2, mean value (%) 65.6 ± 9.2 66 ± 7.5 64.7 ± 12.4 65.6 ± 7.8 65.5 ± 11.5 65.3 ± 8.3 65.8 ± 10.7
Number, n (%) 16 (32.7) 10 (31.3) 6 (37.5) 9 (33.3) 7 (33.3) 8 (32) 8 (34.8)
Norepinephrine rate (μg/kg/minute) 0.31 ± 0.35 0.19 ± 0.14 0.23 ± 0.4 0.22 ± 0.21 0.33 ± 0.39 0.22 ± 0.20 0.33 ± 0.39
Number, n (%) 17 (35) 7 (15) 9 (19) 3 (6) 13 (27) 3 (6) 13 (27)
Fluids crystalloids, n (%) 41 (85) 29 (91) 13 (81) 25 (93) 17 (81) 23 (92) 19 (83)
Colloids, n (%) 14 (29) 8 (25) 3 (19) 6 (22) 5 (24) 5 (20) 6 (26)
Mixed, n (%) 6 (13) 5 (16) 0 (0) 4 (15) 1 (5) 3 (12) 2 (9)
Volume (ml) 1,224 ± 717 1,273 ± 555 1,125 ± 979 1,361 ± 534 1,048 8 ± 83 1,390 ± 545 1,044 ± 842
One patient received norepinephrine, had urinary retention and was not defined as a responder or non-responder. Baseline mixed venous saturation measured in
two patients was 49 and 59 %, respectively. Results are shown as mean ± standard deviation or frequency (percentage). *Statistically significant difference versus
non-responders for that threshold. n number of patients or measurements, NR non-responders, ScvO2 central venous oxygen saturation, R responders
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from 55 ± 76 to 81 ± 87 ml/hour (p < 0.01).
Changes in Doppler RI correlated significantly with
changes in urine output (r = −0.322, p = 0.03) and changes
in MAP (r = −0.443, p < 0.01) but not with changes in PP.Fig. 4 Changes in hemodynamic variables before and after fluid challenge
(MAP) and in pulse pressure (PP). The y-axes show the mean values ± stand
MAP2, PP2, RI2 are values after fluid challengeWe found no correlation between changes in urine output
and changes in MAP or PP. The total amount of fluid was
correlated to changes in MAP (r = 0.32, p = 0.027) and PP
(r = 0.33, p = 0.02) but not to changes in RI (r = 0.24,
p = 0.1) or urine output (r = 0.17, p = 0.24).. a Changes in resistivity index (RI). b Changes in mean arterial pressure
ard deviation. MAP1, PP1, RI1 are values before fluid challenge and
Table 3 Performances of RI, MAP, PP and changes in these variables to predict a significant increase in urine output
Threshold
0.1 ml/kg/hour 0.2 ml/kg/hour 0.3 ml/kg/hour
Variables AUC p 95 % CI AUC p 95 % CI AUC p 95 % CI
RI 0.68 0.04 0.52–0.84 0.73 <0.01 0.58–0.87 0.68 0.03 0.53–0.87
MAP 0.65 0.11 0.49–0.80 0.73 0.01 0.59–0.87 0.76 0.00 0.62–0.89
PP 0.57 0.46 0.40–0.74 0.55 0.52 0.39–0.72 0.55 0.56 0.38–0.72
deltaRI 0.73 0.01 0.59–0.88 0.74 <0.01 0.60–0.88 0.73 0.01 0.59–0.88
deltaMAP 0.54 0.69 0.35–0.72 0.49 0.92 0.32–0.66 0.54 0.61 0.38–0.71
deltaPP 0.55 0.57 0.37–0.73 0.52 0.80 0.35–0.69 0.54 0.64 0.37–0.71
deltaRI, deltaMAP, deltaPP are, respectively, change in resistivity index (RI), mean arterial pressure (MAP), pulse pressure (PP). All these variables are obtained by
dividing absolute change in the considered variable by its baseline value. AUC area under the curve, CI confidence interval
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following a fluid challenge at all thresholds and MAP
predicted an increase at thresholds of 0.2 ml/kg/hour
and 0.3 ml/kg/hour, but not 0.1 ml/kg/hour (Table 3).
During fluid administration, changes in RI but not
changes in systemic hemodynamic variables predicted
an increase in urine output at any of the three thresholds
(Table 3). The diagnostic performances of changes in
RI to predict an increase in urine output are shown
in Table 4.
The changes in RI were observed in oliguric and
non-oliguric patients (Table 5) with no difference in the
magnitude of the effect (interference test; p = 0.24). RI
decreased significantly in AKI and non-AKI patients
(Table 5), with no significant difference in magnitude
(interference test p = 0.22).
A total of 30 (61 %) patients responded to the fluid
challenge by an increase of at least 10 % in MAP or PP
(Table 6). In these patients, RI decreased from 0.75
(0.67–0.81) to 0.73 (0.66–0.79) (p < 0.01). Changes in RI
after fluid challenge in patients who were hemodynamic
non-responders but had increased urine output are
shown in Table 7.
Discussion
This study shows that fluid loading in critically ill patients
with acute circulatory failure was associated with sig-
nificantly decreased RI as assessed by RIAD. In addition,
changes in RI were correlated with changes in urine out-
put and better predicted the increase in urine output after
fluid administration than changes in MAP and PP at the
three urine output thresholds.Table 4 Diagnostic performances of changes in resistivity index to p
Increase in urine output Cut-off on ROC curve Se Sp
0.1 ml/kg/hour 3.3 % 59 % 69 %
0.2 ml/kg/hour 3.3 % 63 % 67 %
0.3 ml/kg/hour 3.3 % 64 % 65 %
Results are expressed as percentages or absolute values as appropriate. NLR negativ
PPV positive predictive value, ROC receiver operating characteristic, Se sensitivity, SpThese data provide interesting insights into the
mechanisms of the renal response to fluids. First, the
decrease in RI suggests that renal perfusion increased
in these patients. The correlation of changes in urine
output with changes in RI but not with changes in
MAP or PP suggests that regional factors play a more
important role than systemic hemodynamic factors in
the regulation of urine production. Direct assessment
of intrarenal vasoreactivity may, therefore, better re-
flect intrarenal pathophysiological features than sys-
temic changes in MAP or PP [18]. Second, renal
responders also had a lower RI at baseline, indicating
that perfusion pressure and renal perfusion were better
preserved in these patients; hence, the effects of fluids
may depend on basal renal hemodynamic conditions.
Third, an improvement in renal perfusion can be obtained
and translated into an increase in urine output even when
there are no relevant (<10 %) changes in MAP. This
observation emphasizes the relative dissociation of sys-
temic and intrarenal hemodynamics. The limited number
of hemodynamic non-responders as assessed by failure to
increase MAP or PP may explain the non-significant trend
for change in RI observed in this subgroup.
The poor ability of systemic hemodynamic variables
to predict an increase in urine output following fluid
challenge was notable. Although renal responders had
higher baseline MAP, changes in MAP and PP were
not associated with renal response to fluids. This
observation is consistent with previous investigations
by Bourgoin et al. [19] and LeDoux et al. [20], which
showed the lack of correlation between changes in
MAP and response in urine output [19, 20] or serumredict increase in urine output
NPV PPV NLR PLR Youden’s Indice
62 % 66 % 0.59 1.90 0.28
64 % 67 % 0.55 1.91 0.30
63 % 66 % 0.55 1.83 0.29
e likelihood ratio, NPV negative predictive value, PLR positive likelihood ratio,
specificity
Table 5 Changes in hemodynamic variables after fluid challenge according to the presence of oliguria or AKI
No-oliguria Oliguria No-AKI AKI
N = 22 N = 27 N = 11 N = 38
Before FC After FC Before FC After FC Before FC After FC Before FC After FC
UO (ml/hour) 53 (37–128) 103 (47–189) 15 (2.5–40) 44 (8–75) 46 (40–102) 86 (49–142) 26 (7–49) 50 (11–104)
RI 0.75 (0.67–0.81) 0.73 (0.65–0.78) 0.74 (0.69–0.80) 0.73 (0.67–0.79) 0.71 (0.61–0.77) 0.68 (0.61–0.74) 0.76 (0.69–0.81) 0.74 (0.66–0.79)
MAP (mmHg) 75 (64–82) 80 (68–94) 69 (64–82) 74 (66–91) 78 (72–94) 90 (78–100) 70 (64–81) 74 (66–90)
PP (mmHg) 50 (44–59) 57 (47–68) 47 (38–63) 52 (47–69) 48 (38–53) 57 (46–63) 48 (42–61) 56 (47–70)
All changes were significant with p < 0.01. Of note, interference between subgroups was not significant. Variables are presented as median and interquartile
range. AKI acute kidney injury, FC fluid challenge, MAP mean arterial pressure, N number of patients, PP pulse pressure, RI resistivity index, UO urine output
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to increase MAP from 65 to 85 mmHg. However,
Deruddre et al. [8] observed an increase in urine out-
put when MAP was increased from 65 to 75 mmHg
using norepinephrine infusion but not when it was
increased further from 75 to 85 mmHg. A possible
deleterious effect of norepinephrine was considered to
explain the observations in the high MAP range.
Interestingly, the norepinephrine infusion rate was
higher in non-responders than in responders in our
renal responsive 0.2 and 0.3 ml/kg/hour groups.
Nevertheless, the norepinephrine infusion rate was
not correlated with changes in urine output or in RI.
The impact of MAP may be affected by individual
factors and, although a minimal MAP is required,
further increases in MAP are often not associated
with improved urine output, creatinine level [21] or renal
hemodynamics.
In apparent contrast to our observations, Schnell et al.
[9] did not observe significant changes in RI in septic
patients who responded to a fluid challenge. However,
these authors defined the response to fluid challenge as
an increase in descending aortic blood flow evaluated by
esophageal Doppler, which is thus a systemic response to
fluid challenge, while we preferred to define the response
to fluids as an increase in urine output. Hence, their study
and ours concur to underline the dissociation between
the systemic and the renal response to fluid challenge.
Our study further emphasizes that an improvement in
renal hemodynamics is essential for the increase inTable 6 Changes in resistivity index in responders and non-respond
in MAP, PP or both
Fluid
responsiveness
Increase in MAP >10 % Increase i
Responsive Non-responsive Responsiv
n = 20 n = 29 n = 27
RI 0.75 (0.70–0.81) 0.75 (0.67–0.80) 0.74 (0.67
RI2 0.73 (0.67–0.79) 0.73 (0.65–0.78) 0.72 (0.66
p <0.01 0.018 <0.01
Variables are shown as median and interquartile range and were compared using W
pulse pressure, RI resistivity index at baseline, RI2 resistivity index after fluid challenurine output to occur. In addition, we show that
changes in MAP and PP, routinely used as surrogates
of improved renal hemodynamics, are poorly associ-
ated with RI and ineffective at predicting an increase
in urine output.
Of note, the changes in renal Doppler variables,
although statistically significant, were relatively lim-
ited. The observed changes in RI were just above the
LSC. Thus, clinical applicability of the observed
differences is questionable, especially if multiple and
potentially less experienced investigators are per-
forming the examinations [22]. Nevertheless, we
showed that, in experienced hands, RI measurements
had excellent reproducibility, precision and stability
over time. To eliminate any impact of inter-observer
variability, one single investigator (MDM) performed all
measurements and we suggest that the same sonographer
should obtain the before and after measurements.
Furthermore, we used strict criteria to define failure
in measurement, resulting in more patients being excluded
than commonly described. Because of these precautions,
the changes observed during fluid challenge were well
above the spontaneous variability of measurements.
The technique has some limitations. First, changes in
RI may not reflect changes in renal perfusion gradient,
as several other confounding factors may be present,
including changes in intrarenal compliance, renal intersti-
tial pressure, heart rate, and intra-abdominal pressure.
Second, pulsed Doppler techniques provide focal mea-
surements that may not reflect heterogeneous changes iners to fluid challenge, defined using a cut-off of a 10 % increase
n PP >10 % Increase in MAP or PP >10 %
e Non-responsive Responsive Non-responsive
n = 22 n = 30 n = 19
–0.81) 0.75 (0.68–0.80) 0.75 (0.67–0.81) 0.75 (0.69–0.78)
–0.78) 0.74 (0.66–0.78) 0.73 (0.66–0.79) 0.74 (0.66–0.78)
0.40 <0.01 0.69
ilcoxon test. MAP mean arterial pressure, n number of patients, PP,
ge
Table 7 Changes in resistivity index in patients who responded to fluid challenge with increased urine output but were
hemodynamic non-responders
Increase in urine output 0.1 ml/kg/hour 0.2 ml/kg/hour 0.3 ml/kg/hour
<10 % increase in MAP
n/n’ (%) 19/32 (59 %) 16/27 (59 %) 14/25 (56 %)
RI 0.70 (0.67–0.77) 0.69 (0.63–0.74) 0.69 (0.62–0.76)
RI2 0.67 (0.63–0.77) 0.67 (0.62–0.73) 0.67 (0.61–0.73)
p <0.01 <0.01 <0.01
<10 % increase in MAP or PP
n/n’ (%) 12/32 (38 %) 10/27 (37 %) 9/25 (36 %)
RI 0.71 (0.67–0.77) 0.71 (0.65–0.76) 0.72 (0.64–0.77)
RI2 0.70 (0.65–0.76) 0.69 (0.64–0.74) 0.67 (0.63–0.75)
p 0.182 0.09 0.08
Variables are shown as median and interquartile range and were compared using Wilcoxon test. MAP mean arterial pressure, n/n’ number of patients/total
number of patients with increased urine output (as a percentage), PP, pulse pressure, RI resistivity index at baseline, RI2 resistivity index after fluid challenge
Moussa et al. Critical Care  (2015) 19:250 Page 8 of 9the vascular tone of the entire kidney. In addition, RI mea-
sured at the ILA level may not indicate afferent arteriolar
or interlobular tone, and these vessels are known to be the
most important site of renal myogenic tone regulation
[18]. Third, we included patients with no AKI and with
different stages of AKI. A recent study on septic patients
showed that MAP was correlated with RI in patients with
normal renal function but not in those with AKI [23].
In our trial, however, the response to fluids did not
differ according to the presence of AKI. We also included
septic patients as well as patients with hypovolemic
and cardiogenic shock; this heterogeneity may limit
the external validity of our results. Fourth, the volume
and the type of fluid used may also be confounding
factors. The use of colloids in some patients may
have affected the oncotic gradient between the two
sides of the glomerular filtration barrier and, thereby,
reduced the glomerular filtration rate, but the changes
in oncotic pressure are likely to have been small. The
use of hydroxyethyl starch, even though limited, may
also have biased our observations. Finally, we did not
measure serum creatinine or urinary chemical content
variations, because changes in these variables are slower
than urine output, and may be influenced by other factors
over time [24, 25].
Conclusions
We showed that fluid administration reduces intrarenal
vasoconstriction and that changes in RI are more effective
than changes in MAP and PP to predict an increase in
urine output after fluid challenge. Dynamic analysis of
intrarenal hemodynamics using RIAD can identify renal
responsive patients. However, the use of RI to guide fluid
therapy for renal hemodynamic management may be
limited by the small magnitude of the changes and
potential technical limitations.Key messages
 Fluid challenge results in reduced intrarenal
vasoconstriction in hemodynamically impaired
ICU patients.
 In hemodynamically impaired patients, changes in
MAP after a fluid challenge cannot predict an
increase in urine output.
 However, changes in renal interlobar artery
resistivity index in these patients can predict an
increase in urine output.
 Nevertheless, interlobar resistivity index cannot
be recommended for routine use, because of the
relatively limited magnitude of the changes and
need for experienced ultrasonographers.
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